GlobalData on MSN
FDA clears SleepRes’ Kricket PAP device for obstructive sleep apnoea
The FDA has granted 510(k) clearance to SleepRes’ KPAP-powered Kricket PAP device for the treatment of obstructive sleep ...
Many are familiar with CPAP machines to treat sleep apnea, but fewer realize an oral appliance is an effective alternative. So how do you know if you’re a good candidate?
Obstructive sleep apnea (OSA) may be associated with an increased risk of developing Parkinson disease, although early treatment with continuous positive airway pressure (CPAP) could help mitigate ...
Certain Philips Respironics DreamStation breathing devices, commonly used for treating sleep apnea, may deliver the incorrect prescription or no therapy at all, the FDA warned in a recall announcement ...
With a career in helping Paducah residents find better sleep, one local surgeon is recognized for his work treating ...
Onlymyhealth on MSN
Can Sleep Apnea Impact Your Weight?
Sleep apnea is a condition that makes you stop breathing while you are sleeping It can affect your health in many ways Here’s ...
Untreated obstructive sleep apnea accelerates cardiovascular aging and raises mortality risk in a long-term study.
PITTSBURGH, Dec. 18, 2025 /PRNewswire/ — Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced four recent regulatory milestones spanning across all stages of its global pipeline: ...
Southern California Pulmonary and Sleep Disorders Medical Center (805-557-9930) announces the expansion of its treatment ...
Chronic sleep deprivation acts as a systemic stressor, elevating risks for cardiovascular disease and metabolic dysregulation while impairing cognitive function.
SleepRes, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Kricket PAP device, powered by Kairos Positive Airway Pressure (KPAP), for the treatment ...
TipRanks on MSN
Nyxoah launches Genio therapy in Netherlands and closes first €22.5 million tranche of convertible notes
Nyxoah ( ($NYXH) ) has issued an update. On December 17, 2025, Nyxoah announced the commercial launch of its Genio hypoglossal neurostimulation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results